- Pfizer CEO Albert Bourla said he hasn’t received his company’s Covid-19 vaccine shot yet, telling CNBC that he and other executives will not “cut the line.”
- The vaccine, which Pfizer developed in partnership with Germany-based BioNTech, is the first to be authorized for emergency use in the U.S. to prevent Covid-19.
- Bourla’s comments come as the first deliveries of doses are set to arrive at more than 100 of the country’s 636 pre-determined distribution sites.
Pfizer CEO Albert Bourla hasn’t received his company’s Covid-19 vaccine shot yet, saying Monday he and other executives will not “cut the line” as U.S. officials kick off a massive effort to distribute the vaccine across the country.
The vaccine, which Pfizer developed in partnership with Germany-based BioNTech, is the first approved for emergency use in the U.S. to prevent Covid-19. The Food and Drug Administration on Friday authorized the vaccine for use in people 16 and older, and the Centers for Disease Control and Prevention on Sunday officially recommended its use.
However, there are limited doses available and as such, the CDC has recommended states prioritize health-care workers and long-term care residents for initial distribution.
Views: